Effects of putative activators of K+ channels in mouse pancreatic β‐cells
Open Access
- 1 November 1989
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 98 (3), 957-965
- https://doi.org/10.1111/j.1476-5381.1989.tb14626.x
Abstract
1 The vasodilator and antihypertensive properties of pinacidil, cromakalim (BRL 34915), nicorandil and minoxidil sulphate may be due, at least in part, to their ability to open K+ channels in vascular smooth muscles. In this study, mouse pancreatic islets were used to determine whether these drugs affect insulin release by acting on K+ channels of β-cells. Their effects were compared to those of diazoxide. 2 Diazoxide caused a dose-dependent inhibition of insulin release by islets incubated with 15 mm glucose (93% at 100 μm). Pinacidil inhibited release by 36 and 72% at 100 and 500 μm, respectively. Cromakalim and nicorandil were less effective (35 and 25% inhibition at 500 μm). Minoxidil sulphate increased insulin release at 500 μm. 3 In the presence of 7 mm glucose and in the absence of Ca2+ (to avoid activation of Ca2+-dependent K+ channels), 86Rb efflux from islet cells was increased by 100–500 μm pinacidil and 500 μm nicorandil, which were, however, less potent than diazoxide. Cromakalim was ineffective, whereas 500 μm minoxidil sulphate decreased the efflux rate. In the absence of glucose and presence of Ca2+, 500 μm cromakalim and minoxidil sulphate inhibited 86Rb efflux. 4 Like diazoxide, pinacidil (500 μm) abolished glucose-induced electrical activity in β-cells and hyperpolarized the membrane. 5 ATP-sensitive K+ currents were studied in single β-cells by the whole cell patch-clamp technique. Pinacidil increased the current less than did diazoxide. In contrast, cromakalim and minoxidil sulphate decreased K+-currents whilst nicorandil was without effect. 6 It is concluded that pinacidil, like diazoxide, inhibits insulin release from β-cells by opening ATP-sensitive K+ channels, whereas the smaller inhibitory effects of cromakalim and nicorandil may involve actions other than on K+ channels in these cells. Minoxidil sulphate potentiates glucose-induced insulin release, probably by inhibiting ATP-sensitive K+ channels. However, all these effects of the vasodilators are only seen at high concentrations and are thus unlikely to occur in vivo.This publication has 43 references indexed in Scilit:
- Effect of a New Vasodilator, Pinacidil (P 1134), on Potassium, Noradrenaline and Serotonin Induced Contractions in Rabbit Vascular TissuesActa Pharmacologica et Toxicologica, 2009
- The potassium channel opener cromakalim (BRL 34915) activates ATP-dependent K+ channels in isolated cardiac myocytesBiochemical and Biophysical Research Communications, 1988
- Similarities in the Mechanism of Action of Two New Vasodilator Drugs: Pinacidil and BRL 34915Journal of Cardiovascular Pharmacology, 1988
- The pharmacology of potassium channels and their therapeutic potentialTrends in Pharmacological Sciences, 1988
- Interaction of diazoxide, tolbutamide and ATP4− on nucleotide-dependent K+ channels in an insulin-secreting cell lineThe Journal of Membrane Biology, 1987
- THE SULPHONYLUREA RECEPTOR MAY BE AN ATP-SENSITIVE POTASSIUM CHANNELThe Lancet, 1985
- Glucose induces closure of single potassium channels in isolated rat pancreatic β-cellsNature, 1984
- Intracellular ATP directly blocks K+ channels in pancreatic B-cellsNature, 1984
- D-Glucose inhibits potassium efflux from pancreatic islet cellsNature, 1978
- Glucose-induced decrease in Rb+ permeability in pancreatic β cellsNature, 1975